Human Immunology News 7.07 February 26, 2019 | |
| |
TOP STORYOne-Step Generation of Modular CAR-T Cells with AAV-Cpf1 Scientists developed a system for efficient generation of chimeric antigen receptor (CAR)-engineered T cells with considerably enhanced features by streamlined genome engineering. [Nat Methods] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Investigators demonstrated that human fetal intestines predominantly contain tumor necrosis factor-α (TNF-α)+CD4+CD69+ T effector memory cells. Single-cell RNA sequencing of fetal intestinal CD4+ T cells showed a T helper 1 phenotype and expression of genes mediating epithelial growth and cell cycling. [Immunity] Abstract | Graphical Abstract Researchers demonstrated that sodium chloride potently promoted T helper 2 (TH2) cell responses on multiple regulatory levels. Sodium chloride enhanced interleukin-4 (IL-4) and IL-13 production while suppressing interferon-γ production in memory T cells. [Sci Transl Med] Abstract | Press Release Scientists investigated the phenotype, function, and clinical relevance of follicular regulatory T cells in patients with allergic rhinitis. [J Allergy Clin Immunol] Abstract | Graphical Abstract The authors detected CD8+ T cells specific toward narcolepsy-relevant peptides presented primarily by narcolepsy type 1 (NT1)-associated HLA types in the blood of 20 patients with NT1 as well as in 52 healthy controls, using peptide-MHC-I multimers labeled with DNA barcodes. [Nat Commun] Full Article Gut Microbiota-Dependent CCR9+CD4+ T Cells Are Altered in Secondary Progressive Multiple Sclerosis Scientists analyzed human CD4+ memory T cells expressing the gut-homing chemokine receptor CCR9 and found a reduced frequency of CCR9+ memory T cells in the peripheral blood of patients with secondary progressive multiple sclerosis relative to healthy controls. [Brain] Full Article Peripheral T Cell Cytotoxicity Predicts T Cell Function in the Tumor Microenvironment The authors evaluated detailed immunological aspects in clinical specimens from non-small cell lung cancer (NSCLC) patients. They analyzed the immune profiles, T cell cytotoxicity, and TCR repertoire of peripheral blood, normal lung tissue, and tumor tissue from NSCLC patients. [Sci Rep] Full Article | Press Release Investigators examined the immunomodulatory capacity of extracts from the human pathogenic filaria Brugia malayi on human monocyte responses in a transcriptome-wide manner to identify associated pathways and diseases. [Sci Rep] Full Article Scientists investigated the composition and function of hepatic killer‐cell Ig‐like receptor (KIR)-expressing NK cells. Matched PBMC and hepatic lymphocytes were isolated from 20 individuals undergoing liver surgery and subsequently phenotypically analyzed for expression of KIRs and markers for tissue residency using flow cytometry. [J Leukoc Biol] Abstract Subscribe to our sister publications: Immunology of Infectious Disease News & Immune Regulation News. | |
| |
REVIEWSImmunometabolism and Natural Killer Cell Responses The authors describe the current understanding of mouse and human natural killer (NK) cell metabolism and the key signaling pathways that mediate metabolic responses in NK cells. [Nat Rev Immunol] Abstract Innate Lymphocytes-Lineage, Localization and Timing of Differentiation Researchers shed light on the identities of innate lymphocytes through the lenses of cell lineage, localization, and timing of differentiation. [Cell Mol Immunol] Abstract The role of a disintegrin and metalloproteinase‐17 (ADAM17) in CD16A cleavage and as a regulatory checkpoint is discussed. Several studies have examined the effects of inhibiting ADAM17 or CD16A cleavage directly during NK cell engagement of Ab‐coated tumor cells, which resulted in strengthened Ab tethering, decreased tumor cell detachment, and enhanced CD16A signaling and cytokine production. [J Leukoc Biol] Abstract Visit our reviews page to see a complete list of reviews in the human immunology research field. | |
| |
INDUSTRY NEWSTorque Announces Clinical Trial Collaboration with Merck Torque announced that it has entered into a clinical trial collaboration agreement with Merck. [Torque Therapeutics] Press Release Torque announced that the first patient has been treated in a Phase I clinical trial to evaluate the safety and tolerability of TRQ-1501 Deep IL-15 Primed T cells in patients with selected relapsed or refractory solid tumors and lymphomas. [Torque Therapeutics] Press Release Allogene Therapeutics, Inc. announced that it has entered into a lease agreement to develop a 118,000 square foot cell therapy manufacturing facility in Newark, California. [Allogene Therapeutics, Inc.] Press Release | |
| |
POLICY NEWSOpen-Access Pioneer Randy Schekman on Plan S and Disrupting Scientific Publishing Nobel laureate Randy Schekman shook up the publishing industry when he launched the open-access journal eLife in 2012. Armed with millions in funding from three of the world’s largest private biomedical charities — the Wellcome Trust, the Max Planck Society and the Howard Hughes Medical Institute — Schekman designed the journal to compete with publishing powerhouses such as Nature, Science and Cell. [Nature News] Editorial Foreign Governments Want to Boost Their Biotech Industries — So They’re Setting Up Shop in Boston Cities and states around the corner and around the country have angled for years to set themselves up as the next Kendall Square, hoping to import some of the magic of Boston’s biotech hub and its job-creating economic engine. Increasingly, foreign governments are pushing for the same. [STAT News] Editorial
| |
EVENTSNEW Gordon Research Conference: Translational Malaria Research in Patients & Populations Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Tumor Immunology (University of Maryland) Research Technologist – Immunology (STEMCELL Technologies Inc.) Postdoctoral Position – Innate Immunity (Universitätsklinikum Carl Gustav Carus Dresden) Postdoctoral Positions – Human Immunology (University of California, San Francisco) Staff Scientist – Immunology (Cellzome) Postdoctoral Fellow – Tumor Immune Evasion (Luxembourg Institute of Health) Postdoctoral Positions – Immunity (UT Southwestern Medical Center) Investigator Positions – Cancer Immunology (University of Alabama Birmingham) Postdoctoral Position – Cytokine-Producing B Cells (Inserm) Postdoctoral Fellow – Immunology (Yonsei Cancer Center) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Human Immunology News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|